tirzepatide judge BREAKING NEWS: Grills FDA Over Access—Here’s What It Means for You Judge Denies OFA's Injunction: Compounded

The pivotal trial, STEP 1, randomized 1,961 adults with a BMI of 30 or higher (or 27 with a weight-related comorbidity) to weekly semaglutide 2.4 mg or placebo, both alongside lifestyle counseling

Tirzepatide 15 mg produced 5.5 kg more weight loss than semaglutide 1 mg (p 25,000 participants in the SURPASS and SURMOUNT programs [1, 2, 3]: Gastrointestinal effects (most common, dose-dependent): Nausea: 12-18% (5 mg), 15-22% (10 mg), 18-28% (15 mg) vs

I did not increase my dose I am still taking the starting dose and it still works

Think of these as small lifestyle tweaks that help your body work with the medication, not against it

The 10mg dose represents an intermediate-to-higher level within this escalation framework and is frequently used to assess doseresponse relationships